These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25378751)

  • 1. China enters the global vaccine market.
    Parry J
    Bull World Health Organ; 2014 Sep; 92(9):626-7. PubMed ID: 25378751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese vaccine products go global: vaccine development and quality control.
    Xu M; Liang Z; Xu Y; Wang J
    Expert Rev Vaccines; 2015 May; 14(5):763-73. PubMed ID: 25697690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global vaccine supply. The increasing role of manufacturers from middle income countries.
    Francis DP; Du YP; Precioso AR
    Vaccine; 2014 Sep; 32(41):5259-65. PubMed ID: 25110294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccines: producers in countries of the Southern hemisphere].
    Bertrand JJ
    Med Trop (Mars); 2007 Aug; 67(4):347-50. PubMed ID: 17926792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better vaccines for healthier life. Part II. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
    Pagliusi S; Tippoo P; Sivaramakrishnan V; Nguyen T;
    Vaccine; 2014 Nov; 32(48):6330-5. PubMed ID: 24923638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Casting off vaccine supply charity -- the pace quickens. CVI goal: quality vaccines for all children.
    CVI Forum; 1995 Oct; (10):9-13. PubMed ID: 12290725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine stability in the context of vaccine delivery in a developing country: India.
    John TJ
    Dev Biol Stand; 1996; 87():19-25. PubMed ID: 8853998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European regulations relevant to the marketing and use of fish vaccines.
    Lee A
    Dev Biol Stand; 1997; 90():341-6. PubMed ID: 9270862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of quality vaccines: the industrial point of view.
    Vandersmissen W
    Vaccine; 1992; 10(13):955-7. PubMed ID: 1471420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
    Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A
    Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Towards a new vaccine economy?].
    Poirot P; Martin JF
    Sante; 1994; 4(3):183-7. PubMed ID: 7921683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
    Gilchrist SA; Nanni A
    Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The countries' point of view.
    Schatzmayr HG
    Vaccine; 1992; 10(13):954. PubMed ID: 1471419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The problems and promise of vaccine markets in developing countries.
    Batson A
    Health Aff (Millwood); 2005; 24(3):690-3. PubMed ID: 15886160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global alliance on vaccines and immunizations. Vaccine promotion is circumventing market forces.
    Ojha RK; Abraham J; Khosla M; Puliyel JM
    BMJ; 2002 Apr; 324(7343):975. PubMed ID: 11965668
    [No Abstract]   [Full Text] [Related]  

  • 18. Modern vaccines. Progress towards vaccines we need and do not have.
    Robbins A
    Lancet; 1990 Jun; 335(8703):1436-8. PubMed ID: 1972216
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulatory pathways for vaccines for developing countries.
    Milstien J; Belgharbi L
    Bull World Health Organ; 2004 Feb; 82(2):128-33. PubMed ID: 15042235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring access to affordable, timely vaccines in emergencies.
    Elder K; Saitta B; Ducomble T; Alia M; Close R; Scheele S; Erickson E; Scourse R; Kahn P; Elder G
    Bull World Health Organ; 2019 Dec; 97(12):851-853. PubMed ID: 31819295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.